Whitcomb & Hess, Inc. Abbott Laboratories Transaction History

Whitcomb & Hess, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 21, 2022	SELL	$96.76 - $112.03 $1,838 - $2,128	-19 Reduced 0.59%	3,193 $309,000
Q2 2022 Aug 04, 2022	SELL	$102.07 - $123.37 $612 - $740	-6 Reduced 0.19%	3,212 $349,000
Q1 2022 Apr 15, 2022	SELL	$114.02 - $139.04 $912 - $1,112	-8 Reduced 0.25%	3,218 $381,000
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $33,272 - $40,740	288 Added 9.8%	3,226 $412,000
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $1,633 - $1,806	-14 Reduced 0.47%	2,938 $347,000
Q2 2021 Jul 22, 2021	BUY	$105.79 - $124.53 $312,292 - $367,612	2,952 New	2,952 $342,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Whitcomb & Hess, Inc., based on Form 13F filings with the SEC.

Stay updated on Whitcomb & Hess, Inc. with notifications on news.